Cosmetics Adverse Event Report Validation Should Be CFSAN Priority - CTFA

FDA's cosmetics adverse reaction reporting process should be revised over the next fiscal year to assuage concerns about the accuracy of the reported information, the Cosmetic, Toiletry and Fragrance Association maintains in comments to the agency Aug. 25.